Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Claudia Ponto"'
Autor:
Jean Yves Douet, Saima Zafar, Armand Perret-Liaudet, Caroline Lacroux, Séverine Lugan, Naima Aron, Herve Cassard, Claudia Ponto, Fabien Corbière, Juan Maria Torres, Inga Zerr, Olivier Andreoletti
Publikováno v:
Emerging Infectious Diseases, Vol 20, Iss 1, Pp 114-117 (2014)
We report the presence of infectivity in erythrocytes, leukocytes, and plasma of 1 person with variant Creutzfeldt-Jakob disease and in the plasma of 2 in 4 persons whose tests were positive for sporadic Creutzfeldt-Jakob disease. The measured infect
Externí odkaz:
https://doaj.org/article/5fc1a55d08814dbc895c7ebe76694a70
Autor:
Pascual Sanchez-Juan, Matthew T Bishop, Gabor G Kovacs, Miguel Calero, Yurii S Aulchenko, Anna Ladogana, Alison Boyd, Victoria Lewis, Claudia Ponto, Olga Calero, Anna Poleggi, Ángel Carracedo, Sven J van der Lee, Thomas Ströbel, Fernando Rivadeneira, Albert Hofman, Stéphane Haïk, Onofre Combarros, José Berciano, Andre G Uitterlinden, Steven J Collins, Herbert Budka, Jean-Philippe Brandel, Jean Louis Laplanche, Maurizio Pocchiari, Inga Zerr, Richard S G Knight, Robert G Will, Cornelia M van Duijn
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0123654 (2014)
We performed a genome-wide association (GWA) study in 434 sporadic Creutzfeldt-Jakob disease (sCJD) patients and 1939 controls from the United Kingdom, Germany and The Netherlands. The findings were replicated in an independent sample of 1109 sCJD an
Externí odkaz:
https://doaj.org/article/cce2b1a8c1a44c87b1539cdd95ccb3a7
Autor:
André Karch, Henrike Manthey, Claudia Ponto, Peter Hermann, Uta Heinemann, Christian Schmidt, Inga Zerr
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e84405 (2013)
BACKGROUND: Since more than a decade ApoE is known to be a strong risk factor for Alzheimer's disease (AD); however, molecular pathways mediating this risk are still unclear. In recent years it has been hypothesized that ApoE might play a role in the
Externí odkaz:
https://doaj.org/article/a690026cbd4b409eadce60892083a4d4
Autor:
Michael D. Geschwind, Christiane Stehmann, Janna Kenny, Sabina Capellari, Ryusuke Ae, Sonia M Vallabh, Leonel T. Takada, Masahito Yamada, Piero Parchi, Tadashi Tsukamoto, Steven J. Collins, Jamie Fong, Nobuo Sanjo, Claudia Ponto, Jean Louis Laplanche, Inga Zerr, Tobias Knipper, Jean Philippe Brandel, Margaret C. Orseth, Peter Hermann, Yosikazu Nakamura, Simon Mead, Stéphane Haïk, Miguel Calero, Tetsuyuki Kitamoto, Tsuyoshi Hamaguchi, Jesús de Pedro-Cuesta, Ignazio Roiter, Roberto Chiesa, Eric Vallabh Minikel, Jiri G. Safar, Hidehiro Mizusawa
Publikováno v:
Neurology
ObjectiveTo determine whether preventive trials in genetic prion disease could be designed to follow presymptomatic mutation carriers to onset of disease.MethodsWe assembled age at onset or death data from 1,094 individuals with high penetrance mutat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0df677495b8ccff64cb7a8d32192e8a0
http://hdl.handle.net/11585/695188
http://hdl.handle.net/11585/695188
Autor:
Matthias Schmitz, Inga Zerr, Walter J. Schulz-Schaeffer, Henrike Manthey, Fabian Fincke, Maren Breithaupt, Tim Friede, Anna Krasnianski, Katharina Kramer, Daniela Varges, Uta Heinemann, Claudia Ponto
Publikováno v:
Journal of Neurology, Neurosurgery, and Psychiatry
Objectives The main objective of the present study is to study the therapeutic efficiency of doxycycline in a double-blinded randomised phase II study in a cohort of patients with sporadic Creutzfeldt-Jakob disease (sCJD). Methods From the National R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45bfed7141646edb6fe0a881ed181766
https://doi.org/10.1136/jnnp-2016-313541
https://doi.org/10.1136/jnnp-2016-313541
Autor:
Piero Parchi, Hidehiro Mizusawa, Claudia Ponto, Nobuo Sanjo, Janna Kenny, Inga Zerr, Jean Louis Laplanche, Tobias Knipper, Miguel Calero, Jiri G. Safar, Yosikazu Nakamura, Stéphane Haïk, Simon Mead, Sabina Capellari, Leonel T. Takada, Ignazio Roiter, Christiane Stehmann, Tadashi Tsukamoto, Sonia M Vallabh, Jamie Fong, Tsuyoshi Hamaguchi, Masahito Yamada, Margaret C. Orseth, Eric Vallabh Minikel, Steven J. Collins, Michael D. Geschwind, Ryusuke Ae, Tetsuyuki Kitamoto, Jean Philippe Brandel, Peter Hermann, Roberto Chiesa, Jesús de Pedro-Cuesta
Regulatory agencies worldwide have adopted programs to facilitate drug development for diseases where the traditional approach of a randomized trial with a clinical endpoint is expected to be prohibitively lengthy or difficult. Here we provide quanti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c8e0da008f2620b8cef736431dd9277
https://doi.org/10.1101/401406
https://doi.org/10.1101/401406
Autor:
Anna Krasnianski, Inga Zerr, Kai Kallenberg, Hans A. Kretzschmar, Uta Heinemann, Daniela Varges, Jasmine Kortt, Walter J. Schulz-Schaeffer, Claudia Ponto
Publikováno v:
European Journal of Epidemiology. 31:187-196
To describe the clinical syndrome and diagnostic tests in patients with genetic prion diseases (gPD) in Germany. Clinical features, MRI, EEG, and CSF markers were studied in 91 patients (28 D178N, 20 E200K, 17 inserts, 13 V210I, 8 P102L, 5 E196K). De
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f853039599afd0e4f38551905858445
https://doi.org/10.1007/s10654-015-0049-y
https://doi.org/10.1007/s10654-015-0049-y
Publikováno v:
Journal of Neurology. 261:877-883
In contrast to other neurodegenerative diseases, sporadic Creutzfeldt-Jakob disease (sCJD) is rarely diagnosed in patients older than 75 years. Data describing the characteristics of sCJD in the very old are rare and inconclusive. Therefore, a histor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14f53b830f740690cbc640811634f318
https://doi.org/10.1007/s00415-014-7283-1
https://doi.org/10.1007/s00415-014-7283-1
Autor:
Séverine Lugan, Saima Zafar, Claudia Ponto, Fabien Corbière, Caroline Lacroux, Inga Zerr, Jean-Yves Douet, Naima Aron, Armand Perret-Liaudet, Juan María Torres, Olivier Andreoletti, Hervé Cassard
Publikováno v:
Emerging Infectious Diseases
Emerging Infectious Diseases, Centers for Disease Control and Prevention, 2014, 20 (1), pp.114-117. ⟨10.3201/eid2001.130353⟩
Repositorio de Resultados de Investigación del INIA
Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria INIA
Emerging Infectious Diseases, Vol 20, Iss 1, Pp 114-117 (2014)
INIA: Repositorio de Resultados de Investigación del INIA
Emerging Infectious Diseases 1 (20), 114-117. (2014)
Emerging Infectious Diseases, 2014, 20 (1), pp.114-117. ⟨10.3201/eid2001.130353⟩
Emerging Infectious Diseases, Centers for Disease Control and Prevention, 2014, 20 (1), pp.114-117. ⟨10.3201/eid2001.130353⟩
Repositorio de Resultados de Investigación del INIA
Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria INIA
Emerging Infectious Diseases, Vol 20, Iss 1, Pp 114-117 (2014)
INIA: Repositorio de Resultados de Investigación del INIA
Emerging Infectious Diseases 1 (20), 114-117. (2014)
Emerging Infectious Diseases, 2014, 20 (1), pp.114-117. ⟨10.3201/eid2001.130353⟩
International audience; We report the presence of infectivity in erythrocytes, leukocytes, and plasma of 1 person with variant Creutzfeldt-Jakob disease and in the plasma of 2 in 4 persons whose tests were positive for sporadic Creutzfeldt-Jakob dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcf725e73b0969eadc4426e55dbf6613
http://europepmc.org/articles/PMC3884712
http://europepmc.org/articles/PMC3884712
Autor:
Claudia Ponto, I. Zerr
Publikováno v:
InFo Neurologie & Psychiatrie. 15:42-49
Das Konzept der Protein-Fehlfaltung als Ursache einer Neurodegeneration wie der Creutzfeldt-Jakob-Erkrankung (CJK) wurde bei der Gruppe der Prionerkrankungen erstmalig beschrieben. Obwohl diese als vergleichsweise selten und exotisch betrachtet werde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11d0ebd82e17ca7fef2d4c353bf9939e
https://doi.org/10.1007/s15005-013-0230-3
https://doi.org/10.1007/s15005-013-0230-3